FDA Import Refusal SCS-4727643-3/11/3 — Ranbaxy Pharmaceuticals Canada
The FDA refused shipment SCS-4727643-3/11/3 from Ranbaxy Pharmaceuticals Canada (Canada) on Apr 14, 2021. The refused product falls under Drugs and Biologics — ROSUVASTATIN CALCIUM. Cited charge: 75 This firm has 3 other import refusals on record.
Refusal details
- Date
- Apr 14, 2021
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61JCY16 ROSUVASTATIN CALCIUM
- Charges
- 75